Increase/Decrease in Cash: The total change in cash for the company over the given period.
Moderna, Inc. (MRNA) had Increase/Decrease in Cash of $-289.00M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$6.85B |
|
$-4.71B |
|
$4.69B |
|
$2.15B |
|
$11.09B |
|
$-4.24B |
|
$297.00M |
|
$-3.94B |
|
$-3.94B |
|
$-4.71B |
|
$-4.71B |
|
$-4.71B |
|
$-4.71B |
|
$-4.24B |
|
$-3.68B |
|
382.00M |
|
382.00M |
|
$-12.33 |
|
$-12.33 |
|
| Balance Sheet Financials | |
$10.32B |
|
$1.95B |
|
$8.10B |
|
$18.43B |
|
$3.02B |
|
$575.00M |
|
$1.56B |
|
$4.57B |
|
$13.85B |
|
$13.85B |
|
$13.85B |
|
382.00M |
|
| Cash Flow Statement Financials | |
$-3.12B |
|
$4.21B |
|
$-1.38B |
|
$3.22B |
|
$2.93B |
|
|
Increase/Decrease in Cash |
$-289.00M |
$305.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.42 |
|
-- |
|
-- |
|
0.04 |
|
0.04 |
|
31.47% |
|
-61.90% |
|
-61.90% |
|
-53.72% |
|
-57.56% |
|
-68.84% |
|
$-3.83B |
|
-- |
|
-- |
|
-- |
|
0.37 |
|
23.23 |
|
7.68 |
|
47.54 |
|
-34.03% |
|
-34.03% |
|
-25.58% |
|
-32.67% |
|
$36.27 |
|
$-10.01 |
|
$-8.16 |
|